ArticlePhlebology2023

Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin.

Christos Karathanos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.